🇺🇸 FDA
Patent

US 11207429

Method and compositions for orally administered contrast agents for MR imaging

granted A61KA61K49/085A61K49/108

Quick answer

US patent 11207429 (Method and compositions for orally administered contrast agents for MR imaging) held by Arizona Board of Regents on Behalf of the University of Arizona expires Mon Dec 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Arizona Board of Regents on Behalf of the University of Arizona
Grant date
Tue Dec 28 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K49/085, A61K49/108, A61K49/124